High mitochondrial respiration and glycolytic capacity represent a metabolic phenotype of human tolerogenic dendritic cells

Journal of Immunology

Volumn 194, Issue 11, 2015, Pages 5174-5186

  Malinarich, Frano ^a,b   Duan, Kaibo ^b   Hamid, Raudhah Abdull ^a,b   Bijin, Au ^a,b   Lin, Wu Xue ^a,b   Poidinger, Michael ^b   Fairhurst, Anna Marie ^b   Connolly, John E ^a,b,c  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b AGENCY FOR SCIENCE   (Singapore)

^c BAYLOR UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CD69 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; LACTIC ACID; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; TRANSCRIPTION FACTOR FOXP3; 3 HYDROXYACYL COENZYME A DEHYDROGENASE; ACETYL COENZYME A ACYLTRANSFERASE; ENOYL COENZYME A HYDRATASE; FATTY ACID; FATTY ACID OXIDATION COMPLEX; ISOMERASE; MULTIENZYME COMPLEX;

ARTICLE; BASAL METABOLIC RATE; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; ENZYME SYNTHESIS; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GENE EXPRESSION REGULATION; GLYCOLYSIS; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; METABOLIC REGULATION; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; NORMAL HUMAN; OXIDATION REDUCTION STATE; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; PLASTICITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; SPARE RESPIRATORY CAPACITY; T LYMPHOCYTE ACTIVATION; TOLEROGENIC DENDRITIC CELL; UPREGULATION; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; GENETICS; IMMUNOLOGY; METABOLISM; MITOCHONDRION; MONONUCLEAR CELL; OXIDATION REDUCTION REACTION; OXYGEN CONSUMPTION; T LYMPHOCYTE;

3-HYDROXYACYL COA DEHYDROGENASES; ACETYL-COA C-ACYLTRANSFERASE; CARBON-CARBON DOUBLE BOND ISOMERASES; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; ELECTRON TRANSPORT CHAIN COMPLEX PROTEINS; ENOYL-COA HYDRATASE; FATTY ACIDS; GLYCOLYSIS; HUMANS; IMMUNE TOLERANCE; LEUKOCYTES, MONONUCLEAR; MITOCHONDRIA; OXIDATION-REDUCTION; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; RACEMASES AND EPIMERASES; SUPEROXIDES; T-LYMPHOCYTES;

EID: 84929646104     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1303316     Document Type: Article

References (35)

1. Steinman, R. M., D. Hawiger, and M. C. Nussenzweig. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21: 685-711.
2. Tisch, R. 2010. Immunogenic versus tolerogenic dendritic cells: a matter of maturation. Int. Rev. Immunol. 29: 111-118.
3. Joffre, O. P., E. Segura, A. Savina, and S. Amigorena. 2012. Cross-presentation by dendritic cells. Nat. Rev. Immunol. 12: 557-569.
4. Takeuchi, O., and S. Akira. 2010. Pattern recognition receptors and inflammation. Cell 140: 805-820.
5. Vicente-Manzanares, M., and F. Sánchez-Madrid. 2004. Role of the cytoskeleton during leukocyte responses. Nat. Rev. Immunol. 4: 110-122.
6. Pearce, E. L., and E. J. Pearce. 2013. Metabolic pathways in immune cell activation and quiescence. Immunity 38: 633-643.
7. Sukumar, M., J. Liu, Y. Ji, M. Subramanian, J. G. Crompton, Z. Yu, R. Roychoudhuri, D. C. Palmer, P. Muranski, E. D. Karoly, et al. 2013. Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. J. Clin. Invest. 123: 4479-4488.
8. van der Windt, G. J., and E. L. Pearce. 2012. Metabolic switching and fuel choice during T-cell differentiation and memory development. Immunol. Rev. 249: 27-42.
9. Everts, B., E. Amiel, G. J. van der Windt, T. C. Freitas, R. Chott, K. E. Yarasheski, E. L. Pearce, and E. J. Pearce. 2012. Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells. Blood 120: 1422-1431.
10. Jantsch, J., D. Chakravortty, N. Turza, A. T. Prechtel, B. Buchholz, R. G. Gerlach, M. Volke, J. Gläsner, C. Warnecke, M. S. Wiesener, et al. 2008. Hypoxia and hypoxia-inducible factor-1a modulate lipopolysaccharideinduced dendritic cell activation and function. J. Immunol. 180: 4697-4705.
11. Krawczyk, C. M., T. Holowka, J. Sun, J. Blagih, E. Amiel, R. J. DeBerardinis, J. R. Cross, E. Jung, C. B. Thompson, R. G. Jones, and E. J. Pearce. 2010. Tolllike receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 115: 4742-4749.
12. Jin, P., T. H. Han, J. Ren, S. Saunders, E. Wang, F. M. Marincola, and D. F. Stroncek. 2010. Molecular signatures of maturing dendritic cells: implications for testing the quality of dendritic cell therapies. J. Transl. Med. 8: 4.
13. Morelli, A. E., and A. W. Thomson. 2007. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 7: 610-621.
14. Ferreira, G. B., F. S. Kleijwegt, E. Waelkens, K. Lage, T. Nikolic, D. A. Hansen, C. T. Workman, B. O. Roep, L. Overbergh, and C. Mathieu. 2012. Differential protein pathways in 1,25-dihydroxyvitamin D3 and dexamethasone modulated tolerogenic human dendritic cells. J. Proteome Res. 11: 941-971.
15. Guo, W., L. Jiang, S. Bhasin, S. M. Khan, and R. H. Swerdlow. 2009. DNA extraction procedures meaningfully influence qPCR-based mtDNA copy number determination. Mitochondrion 9: 261-265.
16. Smyth, G. K. 2004. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3: Article3.
17. Chu, C. C., N. Ali, P. Karagiannis, P. Di Meglio, A. Skowera, L. Napolitano, G. Barinaga, K. Grys, E. Sharif-Paghaleh, S. N. Karagiannis, et al. 2012. Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation. J. Exp. Med. 209: 935-945.
18. Wang, Y., A. W. Mohsen, S. J. Mihalik, E. S. Goetzman, and J. Vockley. 2010. Evidence for physical association of mitochondrial fatty acid oxidation and oxidative phosphorylation complexes. J. Biol. Chem. 285: 29834-29841.
19. Grynberg, A., and L. Demaison. 1996. Fatty acid oxidation in the heart. J. Cardiovasc. Pharmacol. 28(Suppl 1): S11-S17.
20. Gatenby, R. A., and R. J. Gillies. 2004. Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4: 891-899.
21. Kato, Y., S. Ozawa, C. Miyamoto, Y. Maehata, A. Suzuki, T. Maeda, and Y. Baba. 2013. Acidic extracellular microenvironment and cancer. Cancer Cell Int. 13: 89.
22. Griffin, M. D., W. Lutz, V. A. Phan, L. A. Bachman, D. J. McKean, and R. Kumar. 2001. Dendritic cell modulation by 1a,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc. Natl. Acad. Sci. USA 98: 6800-6805.
23. Maldonado, R. A., and U. H. von Andrian. 2010. How tolerogenic dendritic cells induce regulatory T cells. Adv. Immunol. 108: 111-165.
24. Hilkens, C. M., and J. D. Isaacs. 2013. Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now? Clin. Exp. Immunol. 172: 148-157.
25. Harizi, H., M. Juzan, V. Pitard, J. F. Moreau, and N. Gualde. 2002. Cyclooxygenase-2-issued prostaglandin E2 enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J. Immunol. 168: 2255-2263.
26. Valera, I., N. Fernández, A. G. Trinidad, S. Alonso, G. D. Brown, A. Alonso, and M. S. Crespo. 2008. Costimulation of dectin-1 and DC-SIGN triggers the arachidonic acid cascade in human monocyte-derived dendritic cells. J. Immunol. 180: 5727-5736.
27. Hiltunen, J. K., T. Kärki, I. E. Hassinen, and H. Osmundsen. 1986. Betaoxidation of polyunsaturated fatty acids by rat liver peroxisomes. A role for 2,4-dienoyl-coenzyme A reductase in peroxisomal beta-oxidation. J. Biol. Chem. 261: 16484-16493.
28. Ricciotti, E., and G. A. FitzGerald. 2011. Prostaglandins and inflammation. Arterioscler. Thromb. Vasc. Biol. 31: 986-1000.
29. Williard, D. E., T. L. Kaduce, S. D. Harmon, and A. A. Spector. 1998. Conversion of eicosapentaenoic acid to chain-shortened omega-3 fatty acid metabolites by peroxisomal oxidation. J. Lipid Res. 39: 978-986.
30. Everts, B., E. Amiel, S. C. Huang, A. M. Smith, C. H. Chang, W. Y. Lam, V. Redmann, T. C. Freitas, J. Blagih, G. J. van derWindt, et al. 2014. TLR-driven early glycolytic reprogramming via the kinases TBK1-IKK supports the anabolic demands of dendritic cell activation. Nat. Immunol. 15: 323-332.
31. Dumas, J. F., G. Simard, D. Roussel, O. Douay, F. Foussard, Y. Malthiery, and P. Ritz. 2003. Mitochondrial energy metabolism in a model of undernutrition induced by dexamethasone. Br. J. Nutr. 90: 969-977.
32. Somjen, D., S. Katzburg, M. Grafi-Cohen, E. Knoll, O. Sharon, and G. H. Posner. 2011. Vitamin D metabolites and analogs induce lipoxygenase mRNA expression and activity as well as reactive oxygen species (ROS) production in human bone cell line. J. Steroid Biochem. Mol. Biol. 123: 85-89.
33. Pike, L. S., A. L. Smift, N. J. Croteau, D. A. Ferrick, and M. Wu. 2011. Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. Biochim. Biophys. Acta 1807: 726-734.
34. de Moura, M. B., R. Uppala, Y. Zhang, B. Van Houten, and E. S. Goetzman. 2014. Overexpression of mitochondrial sirtuins alters glycolysis and mitochondrial function in HEK293 cells. PLoS ONE 9: e106028. Available at: http:// journals.plos.org/plosone/article?id=10.1371/journal.pone.0106028.
35. Schenk, H., M. Klein, W. Erdbrügger, W. Dröge, and K. Schulze-Osthoff. 1994. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kB and AP-1. Proc. Natl. Acad. Sci. USA 91: 1672-1676.